Background: Nodular hidradenoma is an uncommon, benign, adnexal neoplasm of apocrine origin which is a clinical simulator of other tumours. Objective: The aim of this study was to evaluate the morphological findings of a large series of nodular hidradenomas under dermoscopic observation. Methods: Dermoscopic examination of 28 cases of nodular hidradenomas was performed to evaluate specific dermoscopic criteria and patterns. Results: The most frequently occurring dermoscopic features were: (1) in 96.4% of cases, a homogeneous area that covered the lesion partially or totally, the colour of which was pinkish in 46.4% of cases, bluish in 28.6%, red-blue in 14.3%, and brownish in 10.7%; (2) white structures were found in 89.3% of cases; (3) in 82.1% of cases, vascular structures were also observed, especially arborising telangiectasias (39.3%) and polymorphous atypical vessels (28.6%). Conclusion: Nodular hidradenomas represent a dermoscopic pitfall, being difficult to differentiate clinically and dermoscopically from basal cell carcinomas and melanomas.

Keywords:
Dermoscopy, Nodular hidradenoma, Adnexal tumour
1.
Kazacov DV, Michal M, Kacerovska D, McKee PH: Lesions with predominant apocrine and eccrine differentiation; in Kazakov DV, Michal M, Kacerovska D, Mckee PH (eds): Cutaneous Adnexal Tumors, ed 1. Philadelphia, Wolters Klumer Health/Lippincott Williams & Wilkins, 2012, pp 1-172.
2.
Stratigos AJ, Olbricht S, Kwan TH, Bowers KE: Nodular hidradenoma: a report of three cases and review of the literature. Dermatol Surg 1998;24:387-391.
3.
Sgambato A, Zalaudek I, Ferrara G, Giorgio CM, Moscarella E, Nicolino R, Argenziano G: Adnexal tumors: clinical and dermoscopic mimickers of basal cell carcinoma. Arch Dermatol 2008;144:426.
4.
Yoshida Y, Nakashima K, Yamamoto O: Dermoscopic features of clear cell hidradenoma. Dermatology 2008;217:250-251.
5.
Zaballos P, Bañuls J, Medina C, Salsench E, Serrano P, Guionnet N: Dermoscopy of apocrine hidrocystomas: a morphological study. J Eur Acad Dermatol Venereol 2014;28:378-381.
6.
Zaballos P, Serrano P, Flores G, Bañuls J, et al: Dermoscopy of tumours arising in nevus sebaceous: a morphological study of 58 cases. J Eur Acad Dermatol Venereol 2015, Epub ahead of print.
7.
Zaballos P, Llambrich A, Puig S, Malvehy J: Dermoscopic findings of pilomatricomas. Dermatology 2008;217:225-230.
8.
Lallas A, Moscarella E, Argenziano G, Longo C, Apalla Z, Ferrara G, Piana S, Rosato S, Zalaudek I: Dermoscopy of uncommon skin tumours. Australas J Dermatol 2014;55:53-62.
9.
Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B: Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000;136:1012-1016.
10.
Altamura D, Menzies SW, Argenziano G, Zalaudek I, et al: Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2010;62:67-75.
11.
Menzies SW, Kreusch J, Byth K, Pizzichetta MA, Marghoob A, Braun R, et al: Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008;144:1120-1127.
12.
Zaballos P, Puig S, Llambrich A, Malvehy J: Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol 2008;144:75-83.
13.
Giacomel J, Zalaudek I: Pink lesions. Dermatol Clin 2013;31:649-78.
14.
Zaballos P, Carulla M, Ozdemir F, Zalaudek I, Bañuls J, Llambrich A, Puig S, Argenziano G, Malvehy J: Dermoscopy of pyogenic granuloma: a morphological study. Br J Dermatol 2010;163:1229-1237.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.